ARCHIVES

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

This article is from The Cancer Letter archive.

Vol. 12 No. 01 | January 3, 1986

Download PDF Visit The Full Archive

Related Articles

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979

Also in this 12-page issue: Senate report endorses NCI’s 2015 goal.

July 22, 2005

BMT Ok For some Stage IV Breast Cancer, Blues Advisor Say

March 8, 1996

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996